Related Experiment Videos
Comparing a high-dose dipyridamole SPECT imaging protocol with dobutamine and exercise stress testing protocols
R M Fleming1, C H Rose, K M Feldmann
1Center for Clinical Cardiology and Research, Cedar Rapids, Iowa, USA.
Angiology
|July 1, 1995
Summary
High-dose dipyridamole stress imaging demonstrates superior diagnostic accuracy compared to treadmill protocols for detecting heart disease. This method is safe, with side effects easily reversed by aminophylline.
Area of Science:
- Cardiology
- Nuclear Medicine
- Diagnostic Imaging
Background:
- Standard-dose dipyridamole nuclear imaging yields results comparable to treadmill stress tests.
- Recent studies indicate dobutamine and high-dose dipyridamole do not enhance nuclear imaging results.
Purpose of the Study:
- To evaluate the safety, sensitivity, specificity, and accuracy of high-dose dipyridamole stress imaging.
- Compare high-dose dipyridamole protocols against treadmill and dobutamine stress imaging.
Main Methods:
- 159 patients underwent thallium, teboroxime, or sestamibi single-photon emission computed tomography (SPECT).
- Pharmacologic stress utilized high-dose dipyridamole (0.852 mg/kg over 4 minutes) in 85 patients; others had exercise stress (Bruce protocol).
- Nuclear imaging results were correlated with coronary arteriography findings.
Main Results:
- High-dose dipyridamole achieved 100% sensitivity and 88.9% specificity, significantly exceeding treadmill stress (P < 0.005).
- Dobutamine stress showed 100% sensitivity and specificity in a limited cohort.
- Treadmill stress yielded 92.5% sensitivity and 42.8% specificity.
Conclusions:
- High-dose dipyridamole is a safe stress imaging agent, with adverse effects readily reversed by aminophylline.
- High-dose dipyridamole and dobutamine stress testing demonstrated statistically superior accuracy to treadmill protocols using SPECT.
- SPECT with high-dose dipyridamole offers 100% sensitivity, 88.9% specificity, and 97.9% accuracy for disease detection.